[
    [
        {
            "time": "",
            "original_text": "万泰生物：子公司戊肝疫苗获得巴基斯坦药品注册许可",
            "features": {
                "keywords": [
                    "万泰生物",
                    "戊肝疫苗",
                    "巴基斯坦",
                    "药品注册许可"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药",
                    "生物"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "Correlation": 10,
                "Sentiment": 8,
                "Importance": 7,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 9,
                "Market_Scope": 2,
                "Time_Proximity": 8,
                "Headline_Structure": 7,
                "Source_Recency": 7
            }
        },
        {
            "time": "",
            "original_text": "万泰生物：重组戊型肝炎疫苗注射剂 - 益可宁获得巴基斯坦药品注册许可",
            "features": {
                "keywords": [
                    "万泰生物",
                    "重组戊型肝炎疫苗",
                    "益可宁",
                    "巴基斯坦",
                    "药品注册许可"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药",
                    "生物"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "Correlation": 10,
                "Sentiment": 8,
                "Importance": 7,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 9,
                "Market_Scope": 2,
                "Time_Proximity": 8,
                "Headline_Structure": 7,
                "Source_Recency": 7
            }
        },
        {
            "time": "",
            "original_text": "疫情影響逐漸消退，關注高成長龍頭+細分冠軍 - 医药生物上市公司2020年三季报小结",
            "features": {
                "keywords": [
                    "疫情",
                    "高成长龙头",
                    "细分冠军",
                    "医药生物",
                    "2020年三季报"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药",
                    "生物"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "疫情影響逐漸消退，關注高成長龍頭+細分冠軍 - 医药生物上市公司2020年三季报小结",
                "Correlation": 8,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 5,
                "Market_Scope": 9,
                "Time_Proximity": 4,
                "Headline_Structure": 8,
                "Source_Recency": 3
            }
        }
    ]
]